Ann Leonard currently serves as Vice President of Quality and Regulatory at Elephas, starting in October 2020, where responsibilities include developing quality and regulatory strategies for RUO and IVD products while fostering a quality-centric culture. Prior experience includes various roles at Thermo Fisher Scientific from February 2015 to October 2020, including Senior Director of Quality and Director of Quality, focusing on leading QA/RA projects and implementing quality improvements. Ann Leonard has also served as Director of Material Quality at Mueller Sports Medicine, overseeing compliance with ISO13485 and FDA regulations. Earlier professional roles include a self-employed consultant in medical device quality and regulatory compliance, as well as positions with Mueller Sports Medicine and Promega. Ann's educational background includes a Graduate Certificate in Biopharmaceutical International Regulatory Affairs from Northeastern University, an MBA in Quality Management from Upper Iowa University, and a B.S. in Animal Science from Iowa State University.
This person is not in any offices
Elephas
Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodalmicroscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.